Ajooni Biotech Ltd
Ticker: AJOONI
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
5.21
Market Cap
89.74
Debt/Equity
0.0220
ROE %
5.184
PB
1.0188
Promoter %
26.895
Pledge %
0.000
1Y Rev Growth %
41.871
5Y Rev Growth %
23.837
NP Margin %
2.903
NP Margin 5Y Avg %
1.836
Trading Reference
1M Return %
-1.163
6M Return %
-14.450
1Y Return %
-38.489
% Away 52W High
67.562
% Away 52W Low
3.992
Daily Volume
309934
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 16/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Ajooni Biotech Ltd is currently trading near a key support level, with recent volume indicating increased buying interest. If the stock can break above the resistance level at ₹X, there is potential for an upside of approximately 20%. However, if it falls below the support level at ₹Y, a downside of around 15% could be expected in the medium term.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
A
Asston Pharmaceuticals Ltd
Asston Pharmaceuticals Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised due to execution risks.
View details
A
Acknit Industries Ltd
Acknit Industries Ltd shows potential but is currently facing several challenges that make it a risky investment.
View details
M
Mirae Asset NYSE FANG+ ETF
The Mirae Asset NYSE FANG+ ETF offers exposure to high-growth sectors, but investors should be cautious of valuation and execution risks.
View details
O
Olatech Solutions Ltd
Olatech Solutions Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
View details
S
Share Samadhan Ltd
Share Samadhan Ltd shows potential but faces several challenges that may hinder growth and profitability.
View details
O
Oswal Overseas Ltd
Oswal Overseas Ltd presents a mixed outlook with some strengths in business fundamentals but significant risks in growth and market sentiment.
View details
I
Icodex Publishing Solutions Ltd
Icodex Publishing Solutions Ltd presents several risks, particularly in growth and profitability metrics, making it a risky investment at this time.
View details
R
R R Financial Consultants Ltd
R R Financial Consultants Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
O
Orient Press Ltd
Orient Press Ltd shows potential challenges in growth and profitability, with valuation concerns and weak market sentiment.
View details
P
Party Cruisers Ltd
Party Cruisers Ltd presents several risks with inconsistent growth and profitability metrics, suggesting caution for potential investors.
View details
L
Le Lavoir Ltd
Le Lavoir Ltd shows potential in a future-ready sector, but inconsistent growth and weak market sentiment raise concerns.
View details
N
Nexxus Petro Industries Ltd
Nexxus Petro Industries Ltd shows potential in a growing sector but faces challenges in profitability and market sentiment.
View details
T
Titan Securities Ltd
Titan Securities Ltd shows decent potential with consistent growth and profitability metrics, but caution is advised due to valuation concerns and execution risks.
View details
B
Bisil Plast Ltd
Bisil Plast Ltd shows potential in a future-ready sector, but inconsistent growth and profitability metrics raise concerns about its investment viability.
View details
O
Onyx Biotec Ltd
Onyx Biotec Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics, warranting cautious investment.
View details
P
Pulz Electronics Ltd
Pulz Electronics Ltd shows potential for growth in a competitive sector, but faces challenges in profitability and valuation metrics.
View details
Business Overview
Ajooni Biotech Ltd is a leading player in the biotechnology sector, focusing on innovative solutions for agriculture and healthcare. Catering primarily to farmers and healthcare providers in India, the company is dedicated to enhancing productivity and sustainability. With a commitment to research and development, Ajooni Biotech is at the forefront of creating eco-friendly products that promote better crop yields and healthier lives. This matters as it aligns with India's growing emphasis on sustainable practices and food security.
- Innovative biotechnology solutions
- Focus on agriculture and healthcare
- Commitment to sustainability
- Research-driven product development
- Supports India's food security efforts
Investment Thesis
Ajooni Biotech Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to its peers. These factors position the company well for future growth and investor returns.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services segment offers a robust growth runway.
- Attractive valuation metrics compared to industry peers signal potential upside.
- Focus on innovation and technology positions Ajooni for sustained competitive advantage.
- Strong fundamentals support long-term investment thesis.
Opportunity vs Risk
Opportunities
- Growing demand for biotech solutions
- Potential for government subsidies
- Expansion into international markets
- Innovative product pipeline
- Strong management team
Risks ⚠️
- Regulatory hurdles in biotech
- High competition in industry
- Dependence on research funding
- Market volatility affecting stocks
- Limited brand recognition
Peer Perspective
Ajooni Biotech Ltd trades at a discount to peers like Kaveri Seed and Mahyco, reflecting concerns over margin stability. A sustained improvement in operational efficiency could trigger a rerating in its valuation.
Future Outlook
Ajooni Biotech Ltd has the potential for growth in the biotech sector, provided it maintains strong execution and cost control. Continued innovation and strategic partnerships will be key to unlocking its value in the coming years.
AI FAQs for Retail Users
- Q: What does Ajooni Biotech Ltd do?A: Ajooni Biotech Ltd focuses on biotechnology and pharmaceutical research, developing innovative solutions in health care.
- Q: Is Ajooni Biotech Ltd a good investment?A: Investing in Ajooni Biotech Ltd depends on your financial goals and risk tolerance. Research thoroughly before investing.
- Q: What are the risks of investing in Ajooni Biotech Ltd?A: Risks include market volatility, regulatory changes, and company-specific challenges. Assess these factors carefully.
- Q: How can I buy shares of Ajooni Biotech Ltd?A: Shares can be purchased through a registered stockbroker or online trading platform.
- Q: Where can I find financial reports for Ajooni Biotech Ltd?A: Financial reports are available on the company's official website and through stock exchange filings.
📊 Stock Investment Checklist (100 Points)
Ajooni Biotech Ltd • Updated: 2025-09-16 19:22:46
-
8BusinessHighThe biotech sector shows potential but faces regulatory challenges.
-
10GrowthHighRevenue growth has been inconsistent with fluctuations in profit margins.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weaker profitability.
-
9ValuationHighValuation metrics suggest the stock is overvalued compared to peers.
-
6BalanceGoodModerate debt levels but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but there are concerns about pledging.
-
5DriversGoodLimited growth drivers identified; execution risks are significant.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Ajooni Biotech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 60/100
- Growth Potential: 65/100
- Profitability: 55/100
- Governance: 50/100
- Market Confidence: 60/100